About | Free Trial

Last Update

2015-09-14T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong David Enscore?

Dr. David Enscore J. PhD

Principal Scientist

4P Therapeutics LLC

HQ Phone: (770) 263-1900

4P Therapeutics LLC

150-680 Engineering Drive

Norcross, Georgia 30092

United States

Company Description

4P Therapeutics is a private company focused on the research and development of novel drug delivery technologies and novel drug delivery based therapeutics. The company has capabilities for developing pharmaceutical products from pre-clinical testing to c ... more

Find other employees at this company (5)

Background Information

Employment History

Senior Vice President of Product Devt
LIGHTNING Inc

Vice President, Research, Development and Drug Delivery
Focal, Inc.

Vice President, Research and Development
Ph.D. Joins Spherics , Inc.

Vice President of Research and Development
Micell Technologies Inc

Senior Research and Development Positions
Spherics , Inc.

Manager, Development
Executive Director , Transdermal Product Development

Education

BS

North Carolina State University

Ph.D.

PhD
Chemical Engineering
North Carolina State University

Web References (23 Total References)


Leadership - 4P THERAPEUTICS - Transdermal Research and Development

www.4ptherapeutics.com, $reference.date [cached]

David Enscore, Ph.D. - Principal Scientist

David J. Enscore advises 4P Therapeutics technology selection, product design goals, and analyzes results from product development studies. Over the last several years, he has provided product development direction to the pharmaceutical and medical device industries on a consulting basis. His focus is on controlled drug delivery products in general with a strong emphasis on transdermal drug delivery systems. In a consulting role, he served as Interim Vice President of R&D at Micell Technologies, a company developing a sirolimus eluting, bioabsorbable polymer coated coronary artery stent.
He has served as an expert witness in several patent litigation cases involving transdermal technology. Prior to starting his consulting business, Dr. Enscore was Senior Vice President, Product Research and Development at Altea Therapeutics and was responsible for all product development activities including pharmaceutical science, engineering, clinical R&D, quality assurance, and regulatory affairs. Before joining Altea Therapeutics, he held senior R&D positions at Spherics, Incorporated, an advanced oral drug delivery company and Focal, Incorporated, a company that developed resorbable tissue sealants.
Prior to this, Dr. Enscore worked extensively in transdermal drug delivery, in various scientific and management positions, at Alza Corporation. At Alza, he lead the development of Nicoderm® CQ (transdermal nicotine), the second generation testosterone transdermal system (Testoderm® TTS), and the Actisite® tetracycline periodontal fiber. He has been granted 25 U.S. patents in controlled drug delivery and biodegrabable polymers. Dr. Enscore received a BS and a PhD in Chemical Engineering, with a minor in Polymer Science, from North Carolina State University.


David Enscore, ...

www.4ptherapeutics.com, $reference.date [cached]

David Enscore, Ph.D. Senior Scientific Advisor

David J. Enscore advises 4P Therapeutics technology selection, product design goals, and analyzes results from product development studies. Over the last several years, he has provided product development direction to the pharmaceutical and medical device industries on a consulting basis. His focus is on controlled drug delivery products in general with a strong emphasis on transdermal drug delivery systems. In a consulting role, he served as Interim Vice President of R&D at Micell Technologies, a company developing a sirolimus eluting, bioabsorbable polymer coated coronary artery stent. He has served as an expert witness in several patent litigation cases involving transdermal technology. Prior to starting his consulting business, Dr. Enscore was Senior Vice President, Product Research and Development at Altea Therapeutics and was responsible for all product development activities including pharmaceutical science, engineering, clinical R&D, quality assurance, and regulatory affairs. Before joining Altea Therapeutics, he held senior R&D positions at Spherics, Incorporated, an advanced oral drug delivery company and Focal, Incorporated, a company that developed resorbable tissue sealants. Prior to this, Dr. Enscore worked extensively in transdermal drug delivery, in various scientific and management positions, at Alza Corporation. At Alza, he lead the development of Nicoderm® CQ (transdermal nicotine), the second generation testosterone transdermal system (Testoderm® TTS), and the Actisite® tetracycline periodontal fiber. He has been granted 25 U.S. patents in controlled drug delivery and biodegrabable polymers. Dr. Enscore received a BS and a PhD in Chemical Engineering, with a minor in Polymer Science, from North Carolina State University.


GeorgiaBio: Altea Therapeutics Forms Premier Scientific Advisory Board

www.gabio.org, $reference.date [cached]

David J. Enscore, PhD managed the commercial development of four controlled release pharmaceuticals while at ALZA, a leading drug delivery company subsequently acquired by Johnson & Johnson. He was formerly SVP Product Research and Development at Altea Therapeutics and is an inventor on 25 U.S. patents in drug delivery and medical devices.


GeorgiaBio: Altea Therapeutics Forms Premier Scientific Advisory Board

www.gabio.org, $reference.date [cached]

David J. Enscore, PhD managed the commercial development of four controlled release pharmaceuticals while at ALZA, a leading drug delivery company subsequently acquired by Johnson & Johnson. He was formerly SVP Product Research and Development at Altea Therapeutics and is an inventor on 25 U.S. patents in drug delivery and medical devices.


POD Holding

www.podholding.com, $reference.date [cached]

David J. Enscore, Ph.D., Named Interim President of Spherics, Inc.October 2, 2002, Lincoln, Rhode Island - Spherics, Inc. today announced that David J. Enscore, Ph.D. has been named Interim President, ...

Similar Profiles

Other People with this Name (20)

Other people with the name Enscore

Emory Enscore
Kecoughtan High School

Susan Enscore
Army Corps

Michael Enscore
Home Builders Association of Winston-Salem Inc

Larry Enscore
Waters Edge Church

Melody Enscore
Sage Scientific Writing LLC

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory